Disparities in Neuro-Oncology.

Area of Science:

• Neuro-oncology
• Health Disparities Research
• Clinical Outcomes

Background:

• Health disparities represent preventable differences in diagnosis, treatment, and outcomes for diseases like central nervous system (CNS) tumors.
• These disparities disproportionately impact historically marginalized patient populations.

Purpose of the Study:

• To summarize and compile existing literature on health disparities within neuro-oncology.
• To identify future research directions and intervention strategies for mitigating these disparities.

Main Methods:

• Systematic literature review of studies on health disparities in neuro-oncology.
• Compilation and synthesis of findings regarding patient outcomes, treatment adequacy, and research representation.

Main Results:

• Marginalized groups face inadequate treatment, increased complications, and reduced life expectancy for CNS tumors.
• Financial toxicity is a significant burden for patients undergoing CNS tumor treatment.
• CNS clinical trials and research exhibit a lack of diverse patient representation.

Conclusions:

• Significant health disparities exist in neuro-oncology, negatively impacting marginalized populations.
• Future research and interventions must prioritize addressing financial toxicity and improving diversity in clinical trials.
• Equitable care and outcomes in neuro-oncology require targeted strategies to overcome existing barriers.